{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:42:18Z","timestamp":1791848538360,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.molimm.2015.09.011","type":"journal-article","created":{"date-parts":[[2015,10,21]],"date-time":"2015-10-21T06:55:06Z","timestamp":1445410506000},"page":"272-279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"PA","title":["PLGA (85:15) nanoparticle based delivery of rL7\/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: A promising alternate to traditional adjuvants"],"prefix":"10.1016","volume":"68","author":[{"given":"Damini","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas Kumar","family":"Somani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somya","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2015.09.011_bib0005","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/pi.1697","article-title":"Factors affecting the degradation and drug\u2010release mechanism of poly(lactic acid) and poly[(lactic acid)-co-(glycolic acid)]","volume":"54","author":"Alexis","year":"2005","journal-title":"Polym. Int."},{"key":"10.1016\/j.molimm.2015.09.011_bib0010","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1128\/IAI.62.12.5361-5366.1994","article-title":"Brucella ribosomal protein L7\/L12 is a major component in the antigenicity of brucellin INRA for delayed-type hypersensitivity in brucella-sensitized guinea pigs","volume":"62","author":"Bachrach","year":"1994","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2015.09.011_bib0015","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1615\/CritRevImmunol.v26.i5.30","article-title":"Host immune responses to the intracellular bacteria Brucella: does the bacteria instruct the host to facilitate chronic infection?","volume":"26","author":"Baldwin","year":"2006","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.molimm.2015.09.011_bib0020","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1128\/AAC.00524-10","article-title":"Combination therapy with paromomycin-associated stearylamine-bearing liposomes cures experimental visceral leishmaniasis through Th1-biased immunomodulation","volume":"55","author":"Banerjee","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.molimm.2015.09.011_bib0025","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1128\/IAI.59.9.2978-2986.1991","article-title":"Biodegradable and biocompatible poly(-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin-B toxoid which enhances the level of toxin-neutralizing antibodies","volume":"59","author":"Eldridge","year":"1991","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2015.09.011_bib0030","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1016\/j.vaccine.2006.01.038","article-title":"Experiments on a sub-unit vaccine encapsulated in microparticles and its efficacy against Brucella melitensis in mice","volume":"24","author":"Estevan","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2015.09.011_bib0035","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijpharm.2005.03.035","article-title":"Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model","volume":"298","author":"Foged","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.molimm.2015.09.011_bib0040","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1086\/341449","article-title":"Diminished production of T helper 1 cytokines correlates with T cell unresponsiveness to Brucella cytoplasmic proteins in chronic human brucellosis","volume":"186","author":"Giambartolomei","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molimm.2015.09.011_bib0045","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejpb.2008.03.006","article-title":"Reversible protein precipitation to ensure stability during encapsulation within PLGA microspheres","volume":"70","author":"Giteau","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.molimm.2015.09.011_bib0050","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1051\/vetres:2005003","article-title":"From the discovery of the Malta fever\u2019s agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis","volume":"36","author":"Godfroid","year":"2005","journal-title":"Vet. Res."},{"key":"10.1016\/j.molimm.2015.09.011_bib0055","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.vaccine.2012.12.043","article-title":"Cell mediated immune response after challenge in Omp25 liposome immunized mice contributes to protection against virulent Brucella abortus 544","volume":"31","author":"Goel","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2015.09.011_bib0060","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2013.00017","article-title":"Host-Brucella interactions and the Brucella genome as tools for subunit antigen discovery and immunization against brucellosis","volume":"3","author":"Gomez","year":"2013","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.molimm.2015.09.011_bib0065","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1016\/j.vaccine.2007.01.120","article-title":"Chemical adjuvants for plasmid DNA vaccines","volume":"25","author":"Greenland","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2015.09.011_bib0070","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.4049\/jimmunol.153.11.4925","article-title":"Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class-I Mhc molecules","volume":"153","author":"Harding","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2015.09.011_bib0075","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ijpharm.2011.11.040","article-title":"Stability of lyophilized siRNA nanosome formulations","volume":"423","author":"Kundu","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.molimm.2015.09.011_bib0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061885","article-title":"A single-dose PLGA encapsulated protective antigen domain 4 nanoformulation protects mice against Bacillus anthracis spore challenge","volume":"8","author":"Manish","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2015.09.011_bib0085","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jconrel.2012.07.030","article-title":"Conjunctival vaccination against Brucella ovis in mice with mannosylated nanoparticles","volume":"162","author":"Martins","year":"2012","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.molimm.2015.09.011_bib0090","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1128\/JB.172.7.3569-3576.1990","article-title":"Brucella abortus 16s RNA and lipid-a reveal a phylogenetic relationship with members of the alpha-2 subdivision of the class proteobacteria","volume":"172","author":"Moreno","year":"1990","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.molimm.2015.09.011_bib0095","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0188-4409(03)00020-1","article-title":"Activation and proliferation of T lymphocyte subpopulations in patients with brucellosis","volume":"34","author":"Moreno-Lafont","year":"2003","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.molimm.2015.09.011_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1051\/vetres:2003037","article-title":"Rough vaccines in animal brucellosis: structural and genetic basis and present status","volume":"35","author":"Moriyon","year":"2004","journal-title":"Vet. Res."},{"key":"10.1016\/j.molimm.2015.09.011_bib0105","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jconrel.2007.09.013","article-title":"Nano\/micro technologies for delivering macromolecular therapeutics using poly(,-lactide-co-glycolide) and its derivatives","volume":"125","author":"Mundargi","year":"2008","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.molimm.2015.09.011_bib0110","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.1016\/S0264-410X(01)00177-3","article-title":"A Brucella ovis antigenic complex bearing poly-\u03f5-caprolactone microparticles confer protection against experimental brucellosis in mice","volume":"19","author":"Murillo","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2015.09.011_bib0115","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0168-3659(02)00276-6","article-title":"Modulation of the cellular immune response after oral or subcutaneous immunization with microparticles containing Brucella ovis antigens","volume":"85","author":"Murillo","year":"2002","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.molimm.2015.09.011_bib0120","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijpharm.2003.11.008","article-title":"Influence of the co-encapsulation of different excipients on the properties of polyester microparticle-based vaccine against brucellosis","volume":"271","author":"Murillo","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.molimm.2015.09.011_bib0125","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1365-2567.2001.01258.x","article-title":"Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL\/6 and susceptible BALB\/c mice","volume":"103","author":"Murphy","year":"2001","journal-title":"Immunology"},{"key":"10.1016\/j.molimm.2015.09.011_bib0130","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/jbm.10019","article-title":"Uptake of poly(,-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo","volume":"60","author":"Newman","year":"2002","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.molimm.2015.09.011_bib0135","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1086\/378125","article-title":"Brucellosis and the respiratory system","volume":"37","author":"Pappas","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.molimm.2015.09.011_bib0140","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1473-3099(06)70382-6","article-title":"The new global map of human brucellosis","volume":"6","author":"Pappas","year":"2006","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.molimm.2015.09.011_bib0145","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0378-1135(02)00253-5","article-title":"Epidemiology, zoonotic aspects, vaccination and control\/eradication of brucellosis in India","volume":"90","author":"Renukaradhya","year":"2002","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.molimm.2015.09.011_bib0150","doi-asserted-by":"crossref","DOI":"10.1136\/vr.101979","article-title":"Comparison of depopulation and S19-RB51 vaccination strategies for control of bovine brucellosis in high prevalence areas","volume":"174","author":"Saez","year":"2014","journal-title":"Vet. Rec."},{"key":"10.1016\/j.molimm.2015.09.011_bib0155","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.vetmic.2009.06.021","article-title":"Brucellosis: a re-emerging zoonosis","volume":"140","author":"Seleem","year":"2010","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.molimm.2015.09.011_bib0160","doi-asserted-by":"crossref","first-page":"137","DOI":"10.20506\/rst.32.1.2190","article-title":"Immunity to brucellosis","volume":"32","author":"Skendros","year":"2013","journal-title":"Rev. Sci. Tech. OIE"},{"key":"10.1016\/j.molimm.2015.09.011_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-3659(00)00339-4","article-title":"Biodegradable polymeric nanoparticles as drug delivery devices","volume":"70","author":"Soppimath","year":"2001","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.molimm.2015.09.011_bib0170","doi-asserted-by":"crossref","first-page":"16514","DOI":"10.1073\/pnas.0603362103","article-title":"A B lymphocyte mitogen is a Brucella abortus virulence factor required for persistent infection","volume":"103","author":"Spera","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molimm.2015.09.011_bib0175","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/intimm\/5.8.877","article-title":"Brucella abortus induces a novel cytokine gene-expression pattern characterized by elevated Il-10 and Ifn-gamma in Cd4+ T-Cells","volume":"5","author":"Svetic","year":"1993","journal-title":"Int. Immunol."},{"key":"10.1016\/j.molimm.2015.09.011_bib0180","doi-asserted-by":"crossref","first-page":"839","DOI":"10.20506\/rst.33.3.2322","article-title":"Camelid brucellosis: a review","volume":"33","author":"Wernery","year":"2014","journal-title":"Rev. Sci. Tech. OIE"},{"key":"10.1016\/j.molimm.2015.09.011_bib0185","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1128\/IAI.64.7.2782-2786.1996","article-title":"Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms","volume":"64","author":"Zhan","year":"1996","journal-title":"Infect. Immun."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589015300729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589015300729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T14:45:23Z","timestamp":1692110723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589015300729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0161589015300729"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2015.09.011","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PLGA (85:15) nanoparticle based delivery of rL7\/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: A promising alternate to traditional adjuvants","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2015.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}